SCHEMBL6564729

SCHEMBL6564729

OC(c1ccc(C(F)(F)F)cc1)c1ccccc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 1/20 0.48
TOP2B Q02880 1/20 0.48
PDE2A O00408 1/20 0.44
ACP3 P15309 1/20 0.42
TSHR P16473 4/20 0.41
ALDH1A1 P00352 2/20 0.41
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
HSD11B1 P28845 1/20 0.41
VDR P11473 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
KCNJ5 P48544 1/20 0.39
KCNJ3 P48549 1/20 0.39
GRIN2B Q13224 1/20 0.39
HIF1A Q16665 3/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
PTPN5 P54829 1/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9614053 0.83 PDE2A (0.49) TOP2ATOP2BPDE2AACP3ALDH1A1
SCHEMBL6564562 0.81 TOP2A (0.49) TOP2ATOP2BPDE2AACP3TSHR
SCHEMBL6001430 0.80 ATM (0.47) ACP3TSHRALDH1A1KMT2AHIF1A
SCHEMBL14033737 0.80 PDE2A (0.61) TOP2ATOP2BPDE2AACP3MEN1
SCHEMBL4082510 0.80 TSHR (0.58) ACP3TSHRALDH1A1HIF1ACYP2C9
SCHEMBL30986710 0.80 TSHR (0.58) ACP3TSHRALDH1A1HIF1ACYP2C9
SCHEMBL11854191 0.79 TOP2A (0.48) TOP2ATOP2BACP3TSHRALDH1A1
SCHEMBL477602 0.79 ACP3 (0.53) ACP3TSHRALDH1A1MEN1KMT2A
SCHEMBL477580 0.79 ACP3 (0.53) ACP3TSHRALDH1A1MEN1KMT2A
SCHEMBL29609159 0.79 ACP3 (0.53) ACP3TSHRALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 TOP2A 3424/4885TOP2B 2538/4885PDE2A 1839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.